logo
Denver area nonprofit that feeds thousands loses millions federal funding, group says

Denver area nonprofit that feeds thousands loses millions federal funding, group says

CBS News04-04-2025
When immigrants and asylum seekers came to Colorado from the southern border, the Village Exchange Center on the border of Denver and Aurora stepped up to help.
Through
funding from the federal government
, they fed them, along with other Aurorans, through their food bank and offered them free vaccinations,
job fairs
, and integration programs.
"We're providing wraparound services to get people legal assistance, into jobs, training, getting them health care, Medicaid, WIC, SNAP, any of the benefits that they should be using to become self-sustaining," said co-founder and CEO Amanda Blaurock.
Now, all of that is in jeopardy. Just a few days ago, the federal grant money the center used to help run its program was terminated.
"Based on us potentially providing funding to 'illegal aliens,' were the words," said Blaurock.
Village Exchange lost more than $2 million and may lose $3 million more, which has hurt them.
"We have had to let go of a number of contractors and then move FTEs into different roles that they weren't previously in," said Blaurock.
And their weekly food pantry, which feeds 1,100 families a week, is at risk.
"After June, we will be looking at either cutting our pantries significantly and our team and not being able to provide food services to the community or getting different partners that can provide in-kind support," said Blaurock.
She says cutting funding doesn't get rid of need and worries that if they can't provide services to at-risk communities in Denver, Adams, and Arapahoe counties, it could have a devastating effect on all residents as people look for new ways to survive.
"It really jeopardizes the integrity and health and safety of all people living here," said Blaurock.
Village Exchange Center says they will be reaching out to
donors and the public
to try to fill the funding gap they now face.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Exclusive: Sen. Hawley doesn't want to "experiment" with rural hospital funding
Exclusive: Sen. Hawley doesn't want to "experiment" with rural hospital funding

Axios

time43 minutes ago

  • Axios

Exclusive: Sen. Hawley doesn't want to "experiment" with rural hospital funding

Sen. Josh Hawley (R-Mo.) doesn't want to "experiment" with the "vitally important" funding hospitals receive, he said during an Axios News Shapers event Wednesday. Why it matters: Hawley is positioning himself as a key defender of the Medicaid program, even after voting to cut Medicaid through President Trump's "big, beautiful bill." The cuts to Medicaid include rolling back nearly $1 trillion in funding over the next 10 years, and make changes the provider tax. Driving the news:"My concern is, is what result would it really have?" Hawley asked about the long term affects of the provider tax on rural hospitals. "Would it force us to go out and find new funding in other places?" he asked. "Would it force us to raise taxes in some areas? I don't know the answer that, and I don't want to risk it. I don't want to take the experiment." Hawley commended Republicans for capturing the votes of working class, blue collar Americans, but pointed out that the party now needs to deliver policies that benefit them. "Does that mean that they're in the Republican Party to stay forever? I don't think so," he said. "It means they're giving the Republican Party a shot." Context: Hawley introduced the "Protect Medicaid and Rural Hospitals Act" earlier this month to block any future cuts to Medicaid. His bill would repeal the provider tax moratorium and the reduction of provider tax authority, which would restore part of the money that states rely on to fund their programs. The bill would also double the Rural Health Transformation Fund from $50 billion to $100 billion. By the numbers: About 1.2 million people are enrolled in Medicaid in Missouri, 50% of whom are children. The federal government funds 78% of total Medicaid spending in Missouri, according to a May report from KFF.

Kentucky Politics Insider: Trump, McConnell play nice & is Scott Jennings in for Senate?
Kentucky Politics Insider: Trump, McConnell play nice & is Scott Jennings in for Senate?

Yahoo

timean hour ago

  • Yahoo

Kentucky Politics Insider: Trump, McConnell play nice & is Scott Jennings in for Senate?

Kentucky Politics Insider offers an analysis of Kentucky politics and the conversations that drive decisions. Email reporter Austin Horn at ahorn@ or ping him on social media sites with tips or comments. Given their long history of working together — filled with ups and downs — it wouldn't be totally accurate to call Sen. Mitch McConnell and President Donald Trump 'strange bedfellows.' But it is notable that McConnell has boosted Trump's most recent legislative effort. McConnell was a key ally in Trump's push to pass his far-reaching budget bill, which extended many tax cuts and cut spending on Medicaid, among other things. Though McConnell has supported the large majority of the president's initiatives, the two have traded harsh words since Trump left office after his first term. Trump has used a variety of derogatory terms to refer to McConnell, calling him 'dumb' and insinuating he had a 'death wish' for supporting a piece of legislation Democrats also backed. In this term, Trump has also reserved sharp criticism for McConnell for his opposition to the confirmation of Defense Secretary Pete Hegseth and Robert F. Kennedy Jr. for health secretary. In private, McConnell called the president a 'despicable human being' and a 'narcissist,' according to a recent biography of the senator. The latest chapter in the hot-and-cold relationship took a warm turn, highlighted with McConnell's social media post of a photo with Trump. 'I enjoyed celebrating the passage of One Big Beautiful Bill with President Trump and Senate Republicans tonight at the White House dinner,' McConnell posted to X Friday. Jennings still flirtatious When it comes to discussing the 2026 race for U.S. Senate, don't forget about Scott Jennings. The prominent pundit, who has risen to conservative celebrity status during the Biden and Trump years, made sure that won't happen with his recent comments on a conservative podcast. Eric Bolling, the host, mentioned that 'a lot of people' had been talking about Jennings' potential as a candidate for U.S. Senate. This is true, though talk has cooled somewhat since the field has solidified into three prominent Republicans: Rep. Andy Barr, former AG Daniel Cameron and Lexington tech entrepreneur Nate Morris. The Dawson Springs native demurred in his response, saying he 'hasn't made any announcements about that,' and mentioning that he knew all three of the big name candidates well. He was pretty clear on what, or who, could bring him into the fold. 'I do think politics is a team sport. I think Trump's the head coach and eventually he's gonna weigh in on this,' Jennings said. 'My political advice would be to anybody 'If he calls a play, we're gonna have to run it, and I wouldn't want to run against the president in Kentucky.'' When pressed on if he'd run if Trump tapped him for the seat, Jennings was straightforward: 'I pay close attention to everything the president says.' Morris full of 'it' The contest for the Republican nomination to U.S. Senate has continued to heat up over the last week. The biggest case in point: an ad war between Morris and a political action committee supporting Barr. Continuing with his focus on McConnell, Morris' latest ad displays Cameron and Barr as literal puppets of McConnell. It claims that the two 'stuck with' McConnell when he 'pushed for amnesty for' undocumented immigrants. McConnell has actually been a steadfast opponent of amnesty for undocumented immigrants throughout his Senate career, as evidenced by his comments and votes over the years. The reference to 'amnesty,' according to a Morris spokesperson, comes from McConnell's support for a 2024 bipartisan immigration reform bill that Trump opposed. Most references to 'amnesty' in that bill relate to a section that only allowed an emergency expulsion authority to fully activate when an average of 5,000 or more people entered the country illegally during a seven-day period, opening it up to such criticism when fewer than that number entered. Still, there was no amnesty for undocumented immigrants in the bill. 'I'm sick of watching the elites give handouts to illegals while working-class families struggle,' Morris said in the ad. 'I'll lead the fight against amnesty by stopping all immigration until we deport every single illegal immigrant in America.' Morris has made leaning far right on immigration a part of his platform, calling for a complete moratorium on all immigration for a limited time. He closed stating that he was 'a Trump guy, not a McConnell boy.' The ad is supported by a 'seven-figure' overall television advertising campaign, Morris' spokesperson said. Meanwhile, the political action committee working to help elect Barr is hard at work to bring down Morris' reputation among Republican voters before the first-time candidate even becomes a household name. Focusing on the allegedly 'fake' nature of Morris, the ad from Keep America Great PAC homes in on Morris' business past. It references various actions taken on the subject of diversity. 'As a CEO, Morris was so woke, he signed a pledge promising to support DEI, his company even published a list of gay-owned stores and told employees to shop there,' the ad states. It ends with an expletive-punctuated refrain: 'Fake Nate Morris, fully woke, and full of s—.' Dembo's big haul It's always a head-turning event when a newcomer to politics launches a professional campaign for office. Newly-minted Democratic candidate for Kentucky's 6th Congressional District Zach Dembo did it again on Monday when he announced that he'd raised more than $160,000 just three days after launching his campaign. Let's first acknowledge that candidates very often get their campaign contributions lined up well before they actually enter the race. A quick burst of donations right after announcing is nothing new in politics. But $160,000 is an impressive haul for a first-time candidate. We won't know how the full amount Dembo brings in compares to his peers until the next campaign finance deadline coming up in October. Former Democratic House Caucus Chair Cherlynn Stevenson and former Lexington-Fayette Urban County Councilman David Kloiber both posted respectable numbers in their June 30 reports, with Stevenson leading and Kloiber's personal wealth meaning he could put in much more. Money isn't everything in Central Kentucky politics, though. Kloiber himself far outspent Lexington Mayor Linda Gorton in 2022 when he challenged her from his city council perch, but Gorton marched to an easy reelection victory.

A health care lobbying boom
A health care lobbying boom

Politico

time3 hours ago

  • Politico

A health care lobbying boom

Presented by Driving the Day MONEY TALKS — U.S. health care companies are pouring unprecedented sums of money into lobbying efforts as they vie for influence with the Trump administration and the GOP congressional majority, POLITICO's Amanda Chu reports. Newly released lobbying disclosure reports show the Pharmaceutical Research and Manufacturers of America, the trade group for brand-name drugmakers, spent $7.58 million on lobbying in the second quarter, the highest amount it's spent for the period, according to a POLITICO analysis. Leading members Bristol-Myers Squibb and Merck recorded their highest spending for any quarter. Insurance companies have also boosted spending. AHIP, the industry group, spent $4.05 million in the second quarter, its highest for the period on record. The American Hospital Association, meanwhile, reported $6.15 million, its second-highest for the period. The record spending comes as the Trump administration vies to overhaul the U.S. health care sector, posing the biggest threat to industry profits in years and signaling a broader shift in the relationship between corporate America and the traditionally pro-business Republican Party. President Donald Trump has approved nearly a $1 trillion cut in federal funding for Medicaid, threatened to impose tariffs on pharmaceuticals and demanded that drugmakers lower their prices. Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of vaccines, rolling back Covid-19 guidance for healthy children and healthy pregnant women, and overhauling the CDC's advisory panel on vaccines. 'Historically, the business community has seen total Republican control of D.C. as a period of great opportunity for their legislative priorities,' said Jeffrey Kimbell, president of Kimbell & Associates, which represents large pharmaceutical companies. 'While that is still the case, the current administration and some Republicans in Congress also require some industries to continue their defensive posture.' Lobbying firms with ties to key lawmakers and administration officials are reaping the benefits as companies and trade groups seek inroads with Trump and Republicans in Congress. Tarplin, Downs & Young and Todd Strategy Group ranked among the top firms representing pharmaceutical companies in Washington in the second quarter, according to a POLITICO analysis of disclosures. Each firm has strong GOP connections. Linda Tarplin was HHS's liaison to Congress when George H.W. Bush was president. Dan Todd worked for then-Utah GOP Sen. Orrin Hatch on the Finance Committee. WELCOME TO WEDNESDAY PULSE. This is your friendly CMS reporter, Robert King, filling in for your regular hosts Sophie and Kelly today. I am still picking through thousands of pages of payment rules released last week. If you have any thoughts, or know something I missed, please share at rking@ or khooper@ and sgardner@ and follow along @rking_19, @kelhoops and @sophie_gardnerj. In Congress LAWMAKERS TEE OFF ON MA — After a bruising fight over Medicaid cuts in President Donald Trump's megabill, Republicans and Democrats joined together on a health issue they both agree on: reining in privately run Medicare Advantage plans. Members of the House Ways and Means Committee's oversight and health panels discussed during a hearing Tuesday the need for reforms to the popular program that enables older Americans to receive benefits like hearing and vision care outside of traditional Medicare. Lawmakers blasted the plans for high rates of care denials and overspending. 'We know of concerns about MA plans inflating a patient's level of sickness resulting in higher reimbursements for the plan at taxpayer expense,' said Chair Jason Smith (R-Mo.). 'An estimated $40 billion in 2025 alone.' Rep. Lloyd Doggett(D-Texas), ranking member of the panel's Health Subcommittee, said the plans have been overspending traditional Medicare despite the intention to do the opposite. 'Medicare Advantage was sold as a program to save taxpayer dollars and improve quality of care, but I have found that it is largely disadvantages,' he said. Why it matters: The hearing was a spark of bipartisan comity after months of acrimony surrounding the One Big Beautiful Bill Act, which Congress passed earlier this month. The legislation included more than $1 trillion in cuts to health spending over the next decade, with most cuts coming from Medicaid. Medicare Advantage reforms have long engendered bipartisan support — but not enough to get them through Congress. Lawmakers are making another run. Doggett and Rep. Greg Murphy (R-N.C.), chair of the GOP Doctors Caucus, introduced legislation Monday that would mandate MA contract rates to providers. Some MA plans and hospitals have clashed nationwide over rates, with hospitals complaining about high levels of prior authorization requests. The Prompt and Fair Pay Act would mandate MA plans to reimburse all covered items and services for at least what Medicare pays, noting that some plans pay providers below that line. AROUND THE AGENCIES THEORY LIVES ON — In a new report on Covid-19's origins, Dr. Robert Kadlec, who was a top health official in the first Trump administration, says Chinese military researchers might have played a role in developing the virus, POLITICO's Carmen Paun reports Kadlec, who led the Covid-19 vaccine development program known as Operation Warp Speed, would be well-positioned to push for greater scrutiny of China if the Senate confirms him as assistant secretary of defense for nuclear, chemical and biological defense programs. The White House and congressional Republicans have embraced the hypothesis that a lab leak, and not a natural spillover of the virus from animals to humans, triggered the pandemic that killed millions of people globally. Zooming in: The report, published Monday by the Scowcroft Institute of International Affairs at Texas A&M University's Bush School of Government and Public Service, adds to the assertion by three U.S. intelligence agencies that the pandemic started as an accidental lab leak in Wuhan, China, where the first Covid cases were reported in late 2019. The agencies haven't alleged a Chinese military role. But, but, but: There's still no scientific consensus on how the pandemic began, with many virologists continuing to argue that the virus wasn't engineered and the global outbreak had a natural origin. A spokesperson for the Chinese embassy in Washington pointed to a 2021 report by the Chinese government and World Health Organization-appointed experts that concluded that a lab leak origin was 'extremely unlikely.' The spokesperson called that conclusion 'the authoritative scientific conclusion drawn by the China-WHO joint expert group based on field visits to relevant laboratories in Wuhan and in-depth exchanges with relevant scientific researchers.' While Kadlec's report states that a natural spillover from animals to humans remains a possibility, he argues that's doubtful because the virus contains features from different coronavirus strains that don't exist in nature in close proximity. That makes it unlikely that the virus recombination would have happened naturally, he said. Kadlec's concerns about Covid's lingering effects on the brain conflict with Health Secretary Robert F. Kennedy Jr.'s push to deemphasize Covid vaccination. Given the potential for even mild Covid infections triggering long Covid in children and adults, Kadlec's report calls for efforts to screen and test children. The Trump administration suspended a program offering free tests in March. Public Safety ORGAN OVERSIGHT FAILURES — House lawmakers grilled leaders in the nation's organ procurement and donation system Tuesday after a federal report revealed that an organ procurement organization had operated on patients showing signs of life, POLITICO's Amanda Friedman reports. The House Energy and Commerce Oversight and Investigations Subcommittee's hearing followed a Health Resources and Services Administration investigation into the Kentucky-based OPO, Network for Hope. A report released in March found that the OPO had harvested organs from more than two dozen patients who might not have been definitively deceased, failed to reassess brain function and kept poor records of what happened. Subcommittee Chair John Joyce (R-Pa.) said the findings 'fractured the physician-patient relationship' and demanded accountability from the OPO and the United Network for Organ Sharing, the nonprofit that oversees the national transplant system. Dr. Raymond Lynch, who leads HRSA's Organ Transplant Branch, told lawmakers the issues aren't isolated: 'Unfortunately, it is not limited to [Network for Hope].' Other concerns: Members also raised concerns about systematic racism and whistleblower retaliation. UNOS CEO Maureen McBride faced questions about racial bias lawsuits, while Network for Hope CEO Barry Massa defended his group's procedures but acknowledged communication failures. What's next: HHS warned the OPO could be decertified on Monday. HRSA gave the group until July 28 to submit an initial remediation plan. Names in the News Vincent Bellomo is now an adviser at the Department of Health and Human Services. He most recently was a special assistant to the Secretary of HHS. WHAT WE'RE READING POLITICO's David Lim reports on the confirmation of Terry Cole to head the Drug Enforcement Administration. POLITICO's Katherine Tully-McManus reports that Sen. Elizabeth Warren (D-Mass.) will vote against the Senate's first batch of funding bills — signaling her party that she won't be cooperative in the fall funding fight. The New York Times's Nina Agrawal and Allison Jiang write about the changing face of lung cancer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store